439 related articles for article (PubMed ID: 9300036)
1. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
3. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
6. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
Toyama R; Bende SM; Dhar R
Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
[TBL] [Abstract][Full Text] [Related]
9. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
10. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.
Remenick J; Radonovich MF; Brady JN
J Virol; 1991 Oct; 65(10):5641-6. PubMed ID: 1654461
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
Majello B; Napolitano G; Lania L
AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
[TBL] [Abstract][Full Text] [Related]
13. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
14. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
Berkhout B; Gatignol A; Rabson AB; Jeang KT
Cell; 1990 Aug; 62(4):757-67. PubMed ID: 2201451
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
Jeang KT; Berkhout B
J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
[TBL] [Abstract][Full Text] [Related]
16. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
17. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
Kato H; Sumimoto H; Pognonec P; Chen CH; Rosen CA; Roeder RG
Genes Dev; 1992 Apr; 6(4):655-66. PubMed ID: 1559613
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
[TBL] [Abstract][Full Text] [Related]
20. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
